Abstract: The invention relates to methods of obtaining compositions enriched in hematopoietic stem cells by separating out an enriched fraction of cells expressing the marker CDw109. Methods of obtaining compositions enriched in hematopoietic megakaryocyte progenitor cells are also provided. Compositions enriched for stem cells and populations of cells obtained therefrom are also provided by the invention. Methods of use of the cells are also included.
Type:
Grant
Filed:
November 14, 1994
Date of Patent:
September 9, 1997
Assignees:
Systemix, Inc., The Toronto Hospital Research Institute